Identification and modulation of microenvironment is crucial for effective mesenchymal stromal cell therapy in acute lung injury

American Journal of Respiratory and Critical Care Medicine

Volumn 199, Issue 10, 2019, Pages 1214-1224

  Islam, Diana ^a,b   Huang, Yongbo ^a   Fanelli, Vito ^b,c   Delsedime, Luisa ^c   Wu, Sulong ^a   Khang, Julie ^a,b   Han, Bing ^a,b   Grassi, Alice ^b   Li, Manshu ^a,b   Xu, Yonghao ^a,b   Luo, Alice ^a,b   Wu, Jianfeng ^b   Liu, Xiaoqing ^a   McKillop, Montey ^d   Medin, Jeffery ^d   Qiu, Haibo ^e   Zhong, Nanshan ^a,b   Liu, Mingyao ^c,f,g   Laffey, John ⁱ   Li, Yimin ^a,b,j   Zhang, Haibo ^a,b,c,g,h   more..

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TURIN   (Italy)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e SOUTHEAST UNIVERSITY   (China)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^j NONE   (China)

more..

Author keywords

Acute respiratory distress syndrome; Cell therapy; Fibrosis; Proteome

Indexed keywords

FIBRONECTIN; GLUTATHIONE PEROXIDASE 1; INTERLEUKIN 10; INTERLEUKIN 6; PROTEOME; SCATTER FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY EPITHELIUM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKOCYTE DIFFERENTIAL COUNT; LUNG MECHANICS; LUNG MICROENVIRONMENT; MALE; MESENCHYMAL STROMA CELL; MICRO-COMPUTED TOMOGRAPHY; MICROENVIRONMENT; MOUSE; MOUSE MODEL; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOLOGICAL THERAPY; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; PROCEDURES; PROTEOMICS;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; PROTEOMICS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 85065789775     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201802-0356OC     Document Type: Article

References (50)

1. The ARDS task force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al.Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526–2533.
2. Slutsky AS, Villar J, Pesenti A. Happy 50th birthday ARDS! Intensive Care Med 2016;42:637–639.
3. Walkey AJ, Summer R, Ho V, Alkana P. Acute respiratory distress syndrome: epidemiology and management approaches. Clin Epidemiol 2012;4:159–169.
4. The ARDS network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301–1308.
5. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med 2013;369:2126–2136.
6. Ichikado K, Muranaka H, Gushima Y, Kotani T, Nader HM, Fujimoto K, et al. Fibroproliferative changes on high-resolution CT in the acute respiratory distress syndrome predict mortality and ventilator dependency: a prospective observational cohort study. BMJ Open 2012;2:e000545.
7. Maron-Gutierrez T, Silva JD, Asensi KD, Bakker-Abreu I, Shan Y, Diaz BL, et al. Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice. Crit Care Med 2013;41:e319–e333.
8. Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012; 18:759–765.
9. Salazar KD, Lankford SM, Brody AR. Mesenchymal stem cells produce Wnt isoforms and TGF-B1 that mediate proliferation and procollagen expression by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2009;297:L1002–L1011.
10. Tang N, Zhao Y, Feng R, Liu Y, Wang S, Wei W, et al. Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts. J Cell Mol Med 2014;18:156–169.
11. Yan X, Liu Y, Han Q, Jia M, Liao L, Qi M, et al. Injured microenvironment directly guides the differentiation of engrafted Flk-1(1) mesenchymal stem cell in lung. Exp Hematol 2007;35:1466–1475.
12. Sun Z, Wang C, Shi C, Sun F, Xu X, Qian W, et al. Activated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosis. Int J Mol Med 2014;33: 1097–1109.
13. Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med 2015;3:24–32.
14. Zheng G, Huang L, Tong H, Shu Q, Hu Y, Ge M, et al. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respir Res 2014;15:39.
15. Cabrera-Benitez NE, Parotto M, Post M, Han B, Spieth PM, Cheng WE, et al. Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition. Crit Care Med 2012;40:510–517.
16. Buchweitz JP, Karmaus PW, Harkema JR, Williams KJ, Kaminski NE. Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice. J Pharmacol Exp Ther 2007; 323:675–683.
17. Hubner RH, Gitter W, El Mokhtari NE, Mathiak M, Both M, Bolte H, et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 2008;44:507–517.
18. Scaife M, Pacienza N, Au BC, Wang JC, Devine S, Scheid E, et al. Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes. Gene Ther 2013;20: 24–34.
19. McNeil JB, Shaver CM, Kerchberger VE, Russell DW, Grove BS, Warren MA, et al. Novel method for noninvasive sampling of the distal airspace in acute respiratory distress syndrome. Am J Respir Crit Care Med 2018;197:1027–1035.
20. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003;278:17036–17043.
21. Dekkers BG, Bos IS, Gosens R, Halayko AJ, Zaagsma J, Meurs H. The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma. Am J Respir Crit Care Med 2010;181:556–565.
22. Seminario-Vidal L, Kreda S, Jones L, O’Neal W, Trejo J, Boucher RC, et al. Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of rho- and Ca21-dependent signaling pathways. J Biol Chem 2009;284:20638–20648.
23. Raghavendran K, Nemzek J, Napolitano LM, Knight PR. Aspiration-induced lung injury. Crit Care Med 2011;39:818–826.
24. Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo RO. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis 1983;128:S42–S46.
25. Chambers R. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? Br J Pharmacol 2008;153:S367–S378.
26. MalgorzataWygrecka EJ, Guenther A, Preissner K, Markart P. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thromb Haemost 2008;99: 494–501.
27. Chambers RC, Scotton CJ. Coagulation cascade proteinases in lung injury and fibrosis. Proc Am Thorac Soc 2012;9:96–101.
28. Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011;6:147–163.
29. Sapru A, Wiemels JL, Witte JS, Ware LB, Matthay MA. Acute lung injury and the coagulation pathway: potential role of gene polymorphisms in the protein C and fibrinolytic pathways. Intensive Care Med 2006; 32:1293–1303.
30. Bastarache JA, Wang L, Wang Z, Albertine KH, Matthay MA, Ware LB. Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity. Am J Physiol Lung Cell Mol Physiol 2008;294:L874–L881.
31. Nakagome K, Dohi M, Okunishi K, Tanaka R, Miyazaki J, Yamamoto K. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-b in the lung. Thorax 2006;61:886–894.
32. Hirayama S, Sato M, Loisel-Meyer S, Matsuda Y, Oishi H, Guan Z, et al. Lentivirus IL-10 gene therapy down-regulates IL-17 and attenuates mouse orthotopic lung allograft rejection. Am J Transplant 2013;13: 1586–1593.
33. Wang H, Yang YF, Zhao L, Xiao FJ, Zhang QW, Wen ML, et al. Hepatocyte growth factor gene-modified mesenchymal stem cells reduce radiation-induced lung injury. Hum Gene Ther 2013;24: 343–353.
34. Vlasselaer PV, Borremans B, Gorp UV, Dasch JR, Waal-Malefyt RD. Interleukin 10 inhibits transforming growth factor-beta (TGF-beta) synthesis required for osteogenic commitment of mouse bone marrow cells. J Cell Biol 1994;124:569–577.
35. Lee YH, Marquez AP, Mungunsukh O, Day RM. Hepatocyte growth factor inhibits apoptosis by the profibrotic factor angiotensin II via extracellular signal-regulated kinase 1/2 in endothelial cells and tissue explants. Mol Biol Cell 2010;21:4240–4250.
36. Azuma J, Taniyama Y, Takeya Y, Iekushi K, Aoki M, Dosaka N, et al. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther 2006;13:1206–1213.
37. Mou S, Wang Q, Shi B, Gu L, Ni Z. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts. Kaohsiung J Med Sci 2009;25: 577–587.
38. Shukla MN, Rose JL, Ray R, Lathrop KL, Ray A, Ray P. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Am J Respir Cell Mol Biol 2009;40:643–653.
39. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003;100:8407–8411.
40. Gaebel R, Furlani D, Sorg H, Polchow B, Frank J, Bieback K, et al. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One 2011;6: e15652.
41. Ward PA. Oxidative stress: acute and progressive lung injury. Ann N Y Acad Sci 2010;1203:53–59.
42. Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006;533:222–239.
43. Mendes Arent A, de Souza LF, Walz R, Dafre AL. Perspectives on molecular biomarkers of oxidative stress and antioxidant strategies in traumatic brain injury. BioMed Res Int 2014;2014:723060.
44. Bermejo P, Martin-Aragon S, Benedi J, Susin C, Felici E, Gil P, et al. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer’s disease from mild cognitive impairment. Free Radic Res 2008;42:162–170.
45. Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2011;15:1957–1997.
46. Januel C, El Hentati FZ, Carreras M, Arthur JR, Calzada C, Lagarde M, et al. Phospholipid-hydroperoxide glutathione peroxidase (GPx-4) localization in resting platelets, and compartmental change during platelet activation. Biochim Biophys Acta 2006;1761:1228–1234.
47. Drowley L, Okada M, Beckman S, Vella J, Keller B, Tobita K, et al. Cellular antioxidant levels influence muscle stem cell therapy. Mol Ther 2010;18:1865–1873.
48. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010; 137:288–296.
49. Calfee CS, Ware LB, Glidden DV, Eisner MD, Parsons PE, Thompson BT, et al. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 2011;39:711–717.
50. Metheny NA, Clouse RE, Chang Y-H, Stewart BJ, Oliver DA, Kollef MH. Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med 2006;34:1007–1015.